Search Articles — Sudonull

https://sudonull.com/yandex-tracker-10-advanced-methods-for-automation

Learn how to expand Yandex Tracker's functionality with 10 'workarounds' for task automation, metrics management, and integration. For IT specialists.

https://sudonull.com/claude-code-advanced-learning-and-automation-path-for-dev

In-depth guide to Claude Code for developers: from basics and PSB methodology to advanced Skills, PRD, and context-engineering. Boost development efficiency with an AI agent.

https://sudonull.com/web3-development-advanced-education-for-blockchain-pros

Explore top educational paths for blockchain developers and analysts in Web3. Learn about essential skills, career prospects, and program selection.

https://sudonull.com/graphrag-and-ollama-knowledge-graphs-for-advanced-response-generation

Explore GraphRAG and Ollama for creating advanced RAG systems. Learn how knowledge graphs improve the accuracy of responses, overcoming the limitations of vector search.

https://sudonull.com/rbac-with-statuses-in-jmatrixplatform

Implementation of advanced RBAC with lifecycles and object statuses. Code examples, audit, SQL filtering. For middle/senior developers. Study the mechanisms.

https://lrivo.com/tottenham-in-advanced-talks-for-new-director-of-football

Tottenham is in 'intensive talks' to bring in Sebastien Kehl as their new director of football, aiming to improve their struggling Premier League performance.

https://lrivo.com/knicks-crushed-sixers-30-and-advanced-to-the-eastern-conference-finals

New York destroyed Philadelphia 144:114 with a record in three-pointers. A clean sweep 4-0 and a conference finals berth. Find out the details of the historic game!

https://lrivo.com/carolina-hurricanes-crushed-montreal-and-advanced-to-the-2026-stanley-cup-final

Carolina crushed Montreal 6:1 and advanced to the Stanley Cup Final for the first time since 2006. Statistics, video of goals, Russian legionnaires. Read details on the website.

https://lrivo.com/finland-sensationally-beat-canada-and-advanced-to-the-2026-world-championship-final

Finland crushed Canada 4:2 in the semifinal of the World Hockey Championship. A brace by Helenius and a solo rush by Barkov. Who will play Switzerland in the final? All details.

https://lrivo.com/san-antonio-snatched-victory-in-game-7-and-advanced-to-the-nba-conference-finals

Victor Wembanyama recorded a double-double (22 points, 7 rebounds), and the Spurs beat Oklahoma City 111:103. Find out match details, statistics, and the 2026 NBA finals schedule.

https://lrivo.com/san-antonio-broke-oklahoma-in-game-7-and-advanced-to-the-nba-finals

San Antonio Spurs beat Oklahoma City Thunder (111:103) in Game 7 of the NBA playoffs. Wembanyama scored 22 points. In the Western Conference Finals, the team will face the New York Knicks. Details.

https://lrivo.com/san-antonio-spurs-defeated-oklahoma-city-thunder-and-advanced-to-the-nba-finals-2026

San Antonio Spurs defeated Oklahoma City Thunder 111:103 in the 7th game of the semifinals. In the NBA Finals they will meet New York Knicks. Read the match details and statistics.

https://lrivo.com/1-8-finals-of-the-masters-in-rome-gauff-vs-sierra

Coco Gauff confidently advanced to the 1/8 finals of WTA 1000 in Rome, defeating Valentova. Find out match details, statistics, and a prediction for the meeting with Solana Sierra.

https://lrivo.com/leeds-beats-west-ham-in-fa-cup-penalty-shootout

Leeds United advanced to the FA Cup semi-finals after a dramatic penalty shootout win against West Ham. Read fan reactions and match analysis. Get the full story!

https://lrivo.com/leeds-beats-west-ham-in-fa-cup-thriller

Leeds United advanced to the FA Cup semi-finals after a dramatic 4-2 penalty shootout win against West Ham, following a late comeback and VAR drama. Read the full match report.

Medical Countermeasures | About BARDA (Biomedical Advanced...

https://www.medicalcountermeasures.gov/BARDA

The mission of the Biomedical Advanced Research and Development Authority (BARDA) is to develop medical countermeasures that address the public health and medical consequences of chemical, biological, radiological, and nuclear (CBRN) accidents, incidents and attacks, pandemic influenza, and emerging infectious diseases.

BARDA CBRN VACCINE MEDICAL COUNTERMEASURES PROGRAM

https://www.medicalcountermeasures.gov/barda/cbrn/vaccines

BARDA is interested in advanced development projects for monovalent vaccines against Sudan ebolavirus and Marburg virus. The proposed vaccine candidate: Learn how to apply by visiting the BARDA Broad Agency Announcement page. ERVEBO (previously known as V920) is a live virus vectored vaccine administered by intramuscular injection.

Medical Countermeasures | BARDA Influenza & Emerging Infectious...

https://www.medicalcountermeasures.gov/barda/influenza-and-emerging-infectious-diseases/therapeutics

The BARDA-supported Genentech Phase 3b CENTERSTONE study demonstrated that baloxavir marboxil – an FDA-approved inhibitor of influenza viral replication – significantly reduced transmission from symptomatic index patients to uninfected household contacts.

INFLUENZA & EMERGING INFECTIOUS DISEASES - Medical...

https://www.medicalcountermeasures.gov/barda/influenza-and-emerging-infectious-diseases/pandemic-vaccines-adjuvants

Sep 19, 2019 · The Influenza & Emerging Infectious Diseases (EID) Pandemic Vaccines and Adjuvants Program advances timely and accessible vaccination strategies to mitigate potential future pandemics. The Pandemic Vaccines and Adjuvants Program works to accelerate pandemic response timelines by managing the U.S. National Pre-Pandemic Influenza Vaccine Stockpile (NPIVS) and implementing its strategic use in ...

Medical Countermeasures | BARDA CBRN ANTIBACTERIAL MEDICAL ...

https://www.medicalcountermeasures.gov/barda/cbrn/antimicrobials

BARDA is one of the leading public sector funders of advanced development of antimicrobial therapeutics and diagnostics. By funding preclinical development through regulatory approval and post-marketing commitments of therapeutics and diagnostics, BARDA ensures patients have broad access to these lifesaving medical countermeasures.

BARDA Target Product Profiles (TPP) - Medical Countermeasures

https://medicalcountermeasures.gov/barda/tpp

TPPs define the ideal attributes of products of interest to BARDA and show the ultimate goals of the proposed development effort such as disease indication, patient population, delivery mode, treatment duration, treatment regimen, and standards for clinical efficacy. Ideally, these products will be approved, licensed, or cleared by the U.S. Food and Drug Administration (FDA). TPPs provide ...

BARDA Division of Nonclinical Development (DNCD)

https://www.medicalcountermeasures.gov/barda/dncd

Jan 14, 2026 · DNCD provides nonclinical models, tools, and expertise to advance MCM development for chemical, biological, radiological, and nuclear (CBRN), influenza, and emerging infectious disease priority areas to improve national preparedness and response for emerging public health threats. DNCD provides BARDA and MCM developers the expertise and laboratory capacity to establish and share nonclinical ...

BARDA CBRN Burn & Blast Medical Countermeasures Program

https://www.medicalcountermeasures.gov/barda/cbrn/burn-blast

The mission of the Burn and Blast Medical Countermeasures Program is to support development and integration of transformative medical countermeasures (MCMs) into routine care and to build national preparedness for mass casualty incidents. These include both natural and man-made disasters ranging from forest fires to improvised nuclear detonations and explosions. Our investments address ...

Medical Countermeasures | BARDA Influenza & Emerging Infectious...

https://www.medicalcountermeasures.gov/barda/influenza-and-emerging-infectious-diseases/vaccine-development

Since 2005, BARDA's investments have transformed pandemic influenza vaccine preparedness and seasonal influenza vaccines by enabling the development of multiple manufacturing platforms and formulations. These efforts helped drive the nation's responses to the Zika virus outbreaks (2016) and the COVID-19 pandemic (2020–2023).

Medical Countermeasures | BARDA Project BioShield

https://www.medicalcountermeasures.gov/barda/cbrn/project-bioshield

The objective of Project BioShield is to accelerate the research, development, procurement, and availability of effective medical countermeasures against chemical, biological, radiological, and nuclear (CBRN) agents.